Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
grade D 5.31 -2.57% -0.14
HROW closed down 2.57 percent on Friday, March 22, 2019, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical HROW trend table...

Date Alert Name Type % Chg
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Stochastic Reached Oversold Weakness 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Oversold Stochastic Weakness 0.00%
Mar 21 Calm After Storm Range Contraction -2.57%
Mar 21 Wide Bands Range Expansion -2.57%
Mar 20 Calm After Storm Range Contraction -2.57%
Mar 20 Wide Bands Range Expansion -2.57%
Mar 19 180 Bearish Setup Bearish Swing Setup -4.15%

Older signals for HROW ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Health Pharmaceutical Pharmaceuticals Infectious Diseases Pharmacy Pharmaceutical Industry In China Pharmaceutical Sciences Drug Therapies
Is HROW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 15 Harrow Health, Inc. (NASDAQ:HROW) Delivered A Better ROE Than Its Industry
Mar 14 68 Biggest Movers From Yesterday
Mar 13 Harrow: 4Q Earnings Snapshot
Mar 13 Harrow Health, Inc. (HROW) CEO Mark Baum on Q4 2018 Results - Earnings Call Transcript
Mar 12 Harrow Health beats on revenue
Mar 12 Harrow Health Announces Fourth Quarter 2018 Financial Results
Mar 4 Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019
Feb 28 Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019
Feb 13 Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
Feb 7 Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property
See more HROW news...
Indicators
Indicator Value
52 Week High 7.2
52 Week Low 1.71
Average Volume 261,056
200-Day Moving Average 4.0981
50-Day Moving Average 6.1962
20-Day Moving Average 6.2875
10-Day Moving Average 5.738
Average True Range 0.4919
ADX 26.68
+DI 13.8766
-DI 25.6407
Chandelier Exit (Long, 3 ATRs ) 5.7243
Chandelier Exit (Short, 3 ATRs ) 6.4657
Upper Bollinger Band 7.6302
Lower Bollinger Band 4.9448
Percent B (%b) 0.14
BandWidth 42.710139
MACD Line -0.2601
MACD Signal Line -0.1113
MACD Histogram -0.1488
Fundamentals Value
Market Cap 106.54 Million
Num Shares 20.1 Million
EPS -0.81
Price-to-Earnings (P/E) Ratio -6.56
Price-to-Sales 1.39
Price-to-Book 4.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.60
Resistance 3 (R3) 5.61 5.53 5.55
Resistance 2 (R2) 5.53 5.46 5.52 5.53
Resistance 1 (R1) 5.42 5.41 5.38 5.41 5.52
Pivot Point 5.34 5.34 5.32 5.33 5.34
Support 1 (S1) 5.23 5.27 5.19 5.22 5.10
Support 2 (S2) 5.15 5.22 5.14 5.09
Support 3 (S3) 5.04 5.15 5.07
Support 4 (S4) 5.03